We are 4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate CAS:1276666-12-6 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate
2-Butanone, 4-[(2-aminoethyl)(5-chloro-2-benzoxazolyl)amino]-, methanesulfonate (1:2)
4-[(2-Aminoethyl)(5-chloro-1,3-benzoxazol-2-yl)amino]-2-butanone methanesulfonate (1:2)
Molecular Formula: C15H24ClN3O8S2
Molecular Weight: 473.94900
Physical and Chemical Properties:
Boiling point: /
Melting point: /
Flash point: /
Refractive index: /
Appearance: white powder
25kg cardboard drum or according to customer specified requirements
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Intermediates of Suvorexant CAS:1030377-33-3.
Related News: In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .2-Ethoxybenzoic acid CAS:134-11-2 Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added.4-nitrobenzene-1,3-diamine,sulfuric acid CAS:200295-57-4 In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation.1H-1,2,3-Triazole CAS:288-36-8 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space.